Cargando…

Optimal Timing and Early Intervention With Anticoagulant Therapy for Sepsis-Induced Disseminated Intravascular Coagulation

Optimizing diagnostic criteria to detect specific patients likely to benefit from anticoagulants is warranted. A cutoff of 5 points for the International Society on Thrombosis and Haemostasis overt disseminated intravascular coagulation (DIC) scoring system was determined in the original article, bu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yamakawa, Kazuma, Umemura, Yutaka, Murao, Shuhei, Hayakawa, Mineji, Fujimi, Satoshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714922/ https://www.ncbi.nlm.nih.gov/pubmed/30841721 http://dx.doi.org/10.1177/1076029619835055

Ejemplares similares

Anticoagulant therapies against sepsis‐induced disseminated intravascular coagulation
por: Umemura, Yutaka, et al.
Publicado: (2023)

Concomitant Versus Individual Administration of Antithrombin and Thrombomodulin for Sepsis-Induced Disseminated Intravascular Coagulation: A Nationwide Japanese Registry Study
por: Umemura, Yutaka, et al.
Publicado: (2018)

Age Is Associated With the Efficacy of Anticoagulant Therapies Against Sepsis-Induced Disseminated Intravascular Coagulation
por: Takahashi, Kyosuke, et al.
Publicado: (2021)

Optimal Antithrombin Activity Threshold for Initiating Antithrombin Supplementation in Patients With Sepsis-Induced Disseminated Intravascular Coagulation: A Multicenter Retrospective Observational Study
por: Hayakawa, Mineji, et al.
Publicado: (2018)

The Treatment Intensity of Anticoagulant Therapy for Patients With Sepsis-Induced Disseminated Intravascular Coagulation and Outcomes: A Multicenter Cohort Study
por: Kudo, Daisuke, et al.
Publicado: (2019)

Nationwide registry of sepsis patients in Japan focused on disseminated intravascular coagulation 2011–2013
por: Hayakawa, Mineji, et al.
Publicado: (2018)

Benefit profile of anticoagulant therapy in sepsis: a nationwide multicentre registry in Japan
por: Yamakawa, Kazuma, et al.
Publicado: (2016)

Benefit profile of recombinant human soluble thrombomodulin in sepsis-induced disseminated intravascular coagulation: a multicenter propensity score analysis
por: Yoshimura, Jumpei, et al.
Publicado: (2015)

Non-linear and Interaction Analyses of Biomarkers for Organ Dysfunctions as Predictive Markers for Sepsis: A Nationwide Retrospective Study
por: Umemura, Yutaka, et al.
Publicado: (2022)

Diagnosis of sepsis‐induced disseminated intravascular coagulation and coagulopathy
por: Iba, Toshiaki, et al.
Publicado: (2019)

Pathophysiology of trauma-induced coagulopathy: disseminated intravascular coagulation with the fibrinolytic phenotype
por: Hayakawa, Mineji
Publicado: (2017)

Management of disseminated intravascular coagulation: current insights on antithrombin and thrombomodulin treatments
por: Hayakawa, Mineji
Publicado: (2017)

A summary of the Japan septic disseminated intravascular coagulation study
por: Hayakawa, Mineji, et al.
Publicado: (2018)

Sepsis‐induced disseminated intravascular coagulation: an international estrangement of disease concept
por: Ushio, Noritaka, et al.
Publicado: (2023)

Changes in Mannose-Binding Lectin and Collectin Kidney 1 Levels in Sepsis Patients With and Without Disseminated Intravascular Coagulation
por: Hayakawa, Mineji, et al.
Publicado: (2019)

Recombinant human soluble thrombomodulin in sepsis-induced disseminated intravascular coagulation: a multicenter propensity score analysis
por: Yamakawa, Kazuma, et al.
Publicado: (2013)

Sepsis-associated disseminated intravascular coagulation and its differential diagnoses
por: Iba, Toshiaki, et al.
Publicado: (2019)

A Systematic Summary of Systematic Reviews on Anticoagulant Therapy in Sepsis
por: Murao, Shuhei, et al.
Publicado: (2019)

Prognostic accuracy of different disseminated intravascular coagulation criteria in critically ill adult patients: a protocol for a systematic review and meta-analysis
por: Yoshimura, Jumpei, et al.
Publicado: (2018)

Sepsis and disseminated intravascular coagulation
por: Okamoto, Kohji, et al.
Publicado: (2016)

Bleeding complications of anticoagulant therapy in sepsis-induced disseminated intravascular coagulation
por: Iba, Toshiaki
Publicado: (2016)

Special Issue on “Disseminated Intravascular Coagulation: Current Understanding and Future Perspectives”
por: Yamakawa, Kazuma
Publicado: (2022)

Disseminated intravascular coagulation with increased fibrinolysis during the early phase of isolated traumatic brain injury
por: Wada, Takeshi, et al.
Publicado: (2017)

Pathophysiology of Coagulopathy Induced by Traumatic Brain Injury Is Identical to That of Disseminated Intravascular Coagulation With Hyperfibrinolysis
por: Wada, Takeshi, et al.
Publicado: (2021)

Real‐world evidence on disseminated intravascular coagulation from Japan
por: Hisamune, Ryo, et al.
Publicado: (2023)

Benefit Profile of Thrombomodulin Alfa Combined with Antithrombin Concentrate in Patients with Sepsis-Induced Disseminated Intravascular Coagulation
por: Murao, Atsushi, et al.
Publicado: (2022)

Activated protein C does not increase in the early phase of trauma with disseminated intravascular coagulation: comparison with acute coagulopathy of trauma-shock
por: Jesmin, Subrina, et al.
Publicado: (2016)

Effect of Earlier Door-to-CT and Door-to-Bleeding Control in Severe Blunt Trauma: A Retrospective Cohort Study
por: Murao, Shuhei, et al.
Publicado: (2021)

Disseminated intravascular coagulation with the fibrinolytic phenotype predicts the outcome of patients with out-of-hospital cardiac arrest
por: Wada, Takeshi, et al.
Publicado: (2016)

Enhanced Expression of Cell-Specific Surface Antigens on Endothelial Microparticles in Sepsis-Induced Disseminated Intravascular Coagulation
por: Matsumoto, Hisatake, et al.
Publicado: (2015)

Disseminated Intravascular Coagulation in Sepsis and Associated Factors
por: Rinaldi, Ikhwan, et al.
Publicado: (2022)

Disseminated intravascular coagulation immediately after trauma predicts a poor prognosis in severely injured patients
por: Wada, Takeshi, et al.
Publicado: (2021)

Pharmacokinetics of Recombinant Human Soluble Thrombomodulin in Disseminated Intravascular Coagulation Patients with Acute Renal Dysfunction
por: Hayakawa, Mineji, et al.
Publicado: (2017)

Association of antithrombin with development of trauma-induced disseminated intravascular coagulation and outcomes
por: Wada, Takeshi, et al.
Publicado: (2022)

Impact of Antithrombin Supplementation and Concomitant Anticoagulation Therapy in Pediatric Patients With Disseminated Intravascular Coagulation
por: Nagafuchi, Hiroyuki, et al.
Publicado: (2019)

Effects of combination therapy using antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation
por: Iba, Toshiaki, et al.
Publicado: (2017)

Sepsis-Associated Disseminated Intravascular Coagulation and Thromboembolic Disease
por: Semeraro, Nicola, et al.
Publicado: (2010)

Markers of Inflammation and Infection in Sepsis and Disseminated Intravascular Coagulation
por: Patel, Priya, et al.
Publicado: (2019)

Thrombin-activatable fibrinolysis inhibitor and organ dysfunction in disseminated intravascular coagulation associated with sepsis
por: Hayakawa, M, et al.
Publicado: (2011)

Disseminated intravascular coagulation
por: Venugopal, A
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_d326ggc7tcdjd14hvtd5oqhn2t